Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)

Klineova, S., Farber, R. S., DeAngelis, T., Leung, T., Smith, T., Blanck, R., Zhovtis-Ryerson, L., & Harel, A. (2023). Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2). Multiple Sclerosis Journal, 29(8), 990–1000. https://doi.org/10.1177/13524585231185246
Authors:
Sylvia Klineova
Rebecca Straus Farber
Tracy DeAngelis
Tungming Leung
Tyler Smith
Richard Blanck
Lana Zhovtis-Ryerson
Asaff Harel
Affiliated Authors:
Rebecca Straus Farber
Subjects:
COVID-19 (MeSH)
Multiple Sclerosis (MeSH)
Vaccines (MeSH)
Author Keywords:
disease-modifying therapies
immunology
multiple sclerosis
elink
Publication Type:
Article
Unique ID:
10.1177/13524585231185246
PMID:
37431628
DOI:
10.1177/13524585231185246
Journal:
Multiple Sclerosis Journal
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: